Immucor, Inc. (NASDAQ - BLUD) plays a vital role in making a blood transfusion safe. The company is the United States leader in the placement of fully automated instruments (Galileo and ABS2000) for the three markets it serves; hospital transfusion centers, blood donor centers, and large clinical laboratories. The company recently launched its second generation system, the Galileo, in Europe in June 2002. The results have been outstanding, with over 60 placements in the first twelve months. The Galileo was cleared for marketing in the in the United States on April 26, 2004.
